Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPI Dose: Epinephrine in the Pediatric Intensive Care Unit
NCT05327556Phase 2Terminated
- Sponsor
- Boston Children's Hospital
- Start
- Feb 2023
- Primary completion
- May 2025
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of epinephrine in hypotension (2 arms), sponsored by Boston Children's Hospital. Primary endpoint: Systolic Blood Pressure. Started Feb 2023; status: terminated.
02
Drugs
epinephrine
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT05327556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05327556.